Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma

Hepatology Research

Volumn 41, Issue 6, 2011, Pages 553-563

  Lao, Xiang Ming ^a,b   Wang, Dian ^a   Shi, Ming ^a   Liu, Guipeng ^b   Li, Shengping ^a   Guo, Rongping ^a   Yuan, Yunfei ^a   Chen, Minshan ^a   Li, Jinqing ^a   Zhang, Yaqi ^a   Lin, Xiaojun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Hepatitis B virus DNA; Hepatitis B virus reactivation; Hepatocellular carcinoma; Liver function; Transcatheter arterial chemoembolization

Indexed keywords

CARBOPLATIN; EPIRUBICIN; FLOXURIDINE; GELFOAM; IODINATED POPPYSEED OIL; LOBAPLATIN; MITOMYCIN; VIRUS DNA;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHEMOEMBOLIZATION; CLINICAL FEATURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE EXACERBATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS REACTIVATION;

EID: 79957538724     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00796.x     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981; 2: 1129-33.
3. Llovet JM, Real MI, Montana X etal. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-9.
4. Yuen MF, Chan AO, Wong BC etal. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol 2003; 98: 1181-5.
5. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 136: 699-712.
6. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-42.
7. Bruix J, Llovet JM. Hepatitis B virus and hepatocellular carcinoma. J Hepatol 2003; 39 (Suppl 1): S59-63.
8. Jang JW, Choi JY, Bae SH etal. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. J Hepatol 2004; 41: 427-35.
9. Jang JW, Choi JY, Bae SH etal. A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization. Hepatology 2006; 43: 233-40.
10. Vizzini GB, Luca A, Marino IR. Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma. Ann Intern Med 2003; 138: 691-2.
11. Park JW, Park KW, Cho SH etal. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study. Am J Gastroenterol 2005; 100: 2194-200.
12. Ahmad J, Rhee J, Carr BI. The effects of hepatic artery chemotherapy on viral hepatitis in patients with hepatocellular carcinoma. Dig Dis Sci 2005; 50: 331-5.
13. Nagamatsu H, Kumashiro R, Itano S, Matsugaki S, Sata M. Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC. Hepatol Res 2003; 26: 293-301.
14. Xu J, Wang YH, Xia JL, Ge NL, Chen Y, Ye SL. [Effect of transcatheter arterial chemoembolization on HBV DNA level in primary liver cancer patients.]. Chin J Cancer 2009; 28: 520-3.
15. Shi M, Chen JA, Lin XJ etal. Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China. World J Gastroenterol 2010; 16: 264-9.
16. Yeo W, Lam KC, Zee B etal. Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy. Ann Oncol 2004; 15: 1661-6.
17. Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 2006; 43: 209-20.
18. Yeo W, Chan PK, Zhong S etal. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000; 62: 299-307.
19. Tamori A, Nishiguchi S, Tanaka M etal. Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma. Hepatol Res 2003; 26: 77-80.
20. Hung HH, Su CW, Wu JC, Lee SD. Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen. J Hepatol 2010; 52: 463-5.
21. Lu W, Li YH, Yu ZJ etal. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma. Hepatogastroenterology 2007; 54: 1499-502.
22. Liaw YF. Hepatitis viruses under immunosuppressive agents. J Gastroenterol Hepatol 1998; 13: 14-20.
23. Cheng AL, Hsiung CA, Su IJ etal. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 2003; 37: 1320-8.
24. Carman WF, Fagan EA, Hadziyannis S etal. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991; 14: 219-22.
25. Wu IC, Chow NH, Cheng PN etal. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B. J Med Virol 2007; 79: 663-9.
26. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-8.
27. Caturelli E, Siena DA, Fusilli S etal. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 2000; 215: 123-8.
28. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002; 94: 1747-52.
29. Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int 2004; 24: 210-15.
30. Huo TI, Lee SD, Wu JC. Hepatitis after arterial embolization for hepatocellular carcinoma: viral reactivation or ischemia? Hepatology 2006; 43: 1400-1.